Nitrites/Nitrosamines: The impacts on analytics, but not only

Join our inspiring expert talk on nitrites/nitrosamines:

Description:

Since 2018, nitrosamines have gone from an unexpected impurity issue to a persistent, industry-wide challenge. Detection limits have dropped, analytical complexity has increased and yet analytics alone rarely explain where the risk truly originates. In this expert talk, Daniel Nicolau and Philippe Tschopp step away from the usual webinar format to discuss what has really changed over the past years.

From nitrites in excipients and process influences to evolving expectations and growing development pressure, the conversation looks at why nitrosamine risk is now broader, harder to control, and more relevant than ever. This should be an interactive session, so we will be happy to receive questions and topics to discuss before and during the expert talk session.

Date & Time & Timezone: Mar 19, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

For more information & registration here:

REGISTRATION

Speaker:

Daniel Nicolau

Associate Principal Scientist, Reading Scientific Services Ltd (RSSL)

Daniel Nicolau is an Associate Principal Scientist at Reading Scientific Services Ltd (RSSL), serving as the technical lead for life science chromatography. Daniel has degrees in both Medicinal Chemistry and Chemical Biology, with a specialty in Mass Spectrometry.

Daniel created RSSL’s Extractables and Leachables (E&L), developing bespoke approaches that achieve the challenging scientific rigor while ensuring all testing exceeds regulatory guidelines.

Daniel also started the Nitrosamine impurity testing services, developing an abundance of analytical methods to meeting the ever-changing regulatory landscape and ever more demanding thresholds for an increasing list of nitrosamine species in an array of excipients and finished products.

Philippe Tschopp

Founder Pharma Excipients; www.pharmaexcipients.com; Glatt Pharmaceutical Services

Philippe Tschopp has 25 years experience in the pharmaceutical industry. Both as a supplier of pharmaceutical excipients and in the CDMO business development for oral solid dosage from development at Glatt Pharmaceutical Services.

Covering projects in the field of multiparticulates, solubility enhancement, pediatrics and geriatrics, etc. with a strong interest in excipients, new drug delivery technologies and processes.

Philippe has founded www.pharmaexcipients.com

For more information & registration here:

REGISTRATION

Source: Daniel Nicolau, Philippe Tschopp, Pharma Excipients, webinar Nitrites/Nitrosamines: The impacts on analytics, but not only